Champalimaud Foundation: Difference between revisions

Content deleted Content added

Inline

Revision as of 16:50, 7 November 2016

The Champalimaud Foundation (Portuguese: Fundação Champalimaud) is a private biomedical research foundation. It was created according to the will of the late entrepreneur António de Sommer Champalimaud, in 2004. The complete name of the foundation honors the mother and father of the founder and is Fundação Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud. It is based in Lisbon, Portugal. ^[1]

The mission of the Foundation is "to develop programmes of advanced biomedical research and provide clinical care of excellence, with a focus on translating pioneering scientific discoveries into solutions which can improve the quality of life of individuals around the world."

The foundation undertakes research in the fields of neuroscience and oncology at the modernistic Champalimaud Centre for the Unknown in Lisbon. Research into visual impairment is undertaken via an outreach program.

Executive

Acting President - Leonor Beleza

António Champalimaud Vision Award

The award was established in 2007 to recognise contributions to research into vision. In even numbered years it is awarded for contributions to overall vision research and in odd numbered years for contributions to the alleviation of visual problems, primarily in developing countries.

Recipients

Source: Champalimaud Foundation

2016: Christine Holt (University of Cambridge), Carol Mason (Columbia University), John Flanagan (Harvard Medical School) and Carla Shatz (Stanford University)
2015: Kilimanjaro Centre for Community Ophthalmology (KCCO), Seva Foundation and Seva Canada
2014: Napoleone Ferrara, Joan W. Miller, Evangelos S. Gragoudas, Patricia A. D’Amore, Anthony P. Adamis, George L. King and Lloyd Paul Aiello for the development of Anti-Angiogenic Therapy for Retinal Disease.
2013: Nepal Netra Jyoty Sangh, Eastern Regional Eye Care Programme, Lumbini Eye Institute and Tilganga Institute of Ophthalmology
2012: David Williams for the application of adaptive optics (AO) to the eye; and James Fujimoto, David Huang, Carmen A. Puliafito, Joel S. Schuman & Eric Swanson for the development of optical coherence tomography (OCT)
2011: African Programme for Onchocerciasis Control
2010: J. Anthony Movshon and William Newsome
2009: Helen Keller International
2008: Jeremy Nathans and King-Wai Yau
2007: Aravind Eye Care System

References

^ "Champalimaud Foundation". Champalimaud Foundation. Retrieved 23 June 2015.

This Portugal-related article is a stub. You can help Wikipedia by expanding it.

This organization-related article is a stub. You can help Wikipedia by expanding it.

[1] "Champalimaud Foundation". Champalimaud Foundation. Retrieved 23 June 2015.

[1]

@@ Line 13: / Line 13: @@
 ===Recipients===
-Source: [http://fchampalimaud.org/en/vision-award/ Champalimaud Foundation]
+Source: [http://www.fchampalimaud.org/en/vision-award/ Champalimaud Foundation]
+*2016: [[Christine Holt]] (University of Cambridge), Carol Mason (Columbia University), John Flanagan (Harvard Medical School) and [[Carla Shatz]] (Stanford University)
 *2015: [http://www.kcco.net/ Kilimanjaro Centre for Community Ophthalmology (KCCO)], [[Seva Foundation]] and [http://www.seva.ca/ Seva Canada]
 *2014:  [[Napoleone Ferrara]], [[Joan Miller|Joan W. Miller]], Evangelos S. Gragoudas, Patricia A. D’Amore, Anthony P. Adamis, George L. King and Lloyd Paul Aiello ''for the development of Anti-Angiogenic Therapy for Retinal Disease''.